OPTIMIZING TREATMENT WITH LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Loebel, Antony [1 ,2 ]
Silva, Robert [1 ,2 ]
Goldman, Robert [1 ,2 ]
Watabbe, Kei [1 ,2 ]
Pikalov, Andrei [1 ,2 ]
Cucchiaro, Josephine [1 ,2 ]
Kane, John M. [3 ]
机构：
[1] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Marlborough, MA USA
[2] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
[3] Hofstra North Shore LIJ Sch Med, Psychiat & Mol Med, Uniondale, NY USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2114720
引用
收藏
页码：S321 / S321
页数：1
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia
    Pierre, Joseph M.
    Peloian, John H.
    Wirshing, Donna A.
    Wirshing, William C.
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 705 - 710
  • [32] The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial
    Tek, Cenk
    Palmese, Laura B.
    Krystal, Andrew D.
    DeGeorge, Pamela C.
    Reutenauer, Erin L.
    Guloksuz, Sinan
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 341S - 342S
  • [33] Lurasidone for maintenance of efficacy in patients with schizophrenia: a double-blind, placebo-controlled, randomised withdrawal study
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S559 - S560
  • [34] Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomized, double-blind, placebo-controlled trial
    Akhondzadeh, Shahin
    Bayanati, Samaneh
    Mozen-Zadeh, Ehsan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (06) : 1206 - 1206
  • [35] Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Allen, Michael H.
    Feifel, David
    Lesem, Michael D.
    Zimbroff, Daniel L.
    Ross, Ruth
    Munzar, Patrik
    Spyker, Daniel A.
    Cassella, James V.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1313 - 1321
  • [36] Treatment of early rheumatoid arthritis with minocycline or placebo - Results of a randomized, double-blind, placebo-controlled trial
    ODell, JR
    Haire, CE
    Palmer, W
    Drymalski, W
    Wees, S
    Blakely, K
    Churchill, M
    Eckhoff, PJ
    Weaver, A
    Doud, D
    Erikson, N
    Dietz, F
    Olson, R
    Maloley, P
    Klassen, LW
    Moore, GF
    ARTHRITIS AND RHEUMATISM, 1997, 40 (05): : 842 - 848
  • [37] A Double-Blind, Randomized, and Placebo-Controlled Trial of Buspirone Added to Risperidone in Patients With Chronic Schizophrenia
    Ghaleiha, Ali
    Noorbala, Ahmad Ali
    Farnaghi, Farhad
    Hajiazim, Mohammad
    Akhondzadeh, Shahin
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (06) : 678 - 682
  • [38] CLONAZEPAM TREATMENT OF CHRONIC-SCHIZOPHRENIA - NEGATIVE RESULTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    KARSON, CN
    WEINBERGER, DR
    BIGELOW, L
    WYATT, RJ
    AMERICAN JOURNAL OF PSYCHIATRY, 1982, 139 (12): : 1627 - 1628
  • [39] Probiotics for patients with bipolar or schizophrenia spectrum disorder: A double-blind, randomized placebo-controlled trial
    Borkent, Jenny
    Ioannou, Magda
    Haarman, Bartholomeus C. M.
    Sommer, Iris E. C.
    BIPOLAR DISORDERS, 2023, 25 : 82 - 82
  • [40] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    ARANA, GW
    SANTOS, AB
    LARAIA, MT
    MCLEODBRYANT, S
    BEALE, MD
    RAMES, LJ
    ROBERTS, JM
    DIAS, JK
    MOLLOY, M
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
12345